Related Experiment Video
Updated: May 20, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
Ayurvedic intervention in metastatic liver disease
Sanjeev Rastogi1, Ranjana Rastogi
1Department of Pancha-Karma, State Ayurvedic College, Lucknow, India. rastogisanjeev@rediffmail.com
Ayurvedic medicine showed significant improvement in a patient with metastatic liver disease when conventional therapies were not feasible. This case highlights the need to weigh potential benefits against heavy metal toxicity in Ayurvedic treatments for incurable conditions.
Area of Science:
- Integrative oncology
- Ayurvedic medicine
- Clinical case study
Background:
- Ayurvedic medicine is typically used for chronic conditions, with limited evaluation for acute or terminal illnesses.
- A patient with metastatic liver disease and abnormal liver function, for whom conventional therapies were not feasible, was considered for Ayurvedic intervention.
- Family and caregivers declined other interventions, making Ayurvedic treatment the sole option.
Observation:
- A patient diagnosed with metastatic liver disease presented with abnormal liver function and symptoms.
- The patient underwent Ayurvedic therapies for a 10-day observation period.
- Clinical and biochemical parameters were monitored for changes during the treatment period.
Findings:
- Significant clinical improvement was observed in the patient after 10 days of Ayurvedic treatment.
- Biochemical markers associated with liver function showed substantial improvement.
- The positive effects were sustained at a 1-week follow-up post-discharge.
Implications:
- This case suggests Ayurvedic interventions may offer benefits in advanced, incurable liver disease when other options are exhausted.
- It raises critical questions about the risk-benefit ratio of heavy metals in Ayurvedic formulations for severe conditions.
- Further research is warranted to explore the safety and efficacy of Ayurvedic medicine in palliative and advanced oncological care.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
